TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive “Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate November 7, 1975